Literature DB >> 20160270

Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women.

Gypsyamber D'Souza1, Joel M Palefsky, Ye Zhong, Howard Minkoff, L Stewart Massad, Kathy Anastos, Alexandra M Levine, Michael Moxley, Xiao N Xue, Robert D Burk, Howard D Strickler.   

Abstract

Marijuana use was recently reported to have a positive cross-sectional association with human papillomavirus (HPV)-related head and neck cancer. Laboratory data suggest that marijuana could have an immunomodulatory effect. Little is known, however, regarding the effects of marijuana use on cervical HPV or neoplasia. Therefore, we studied the natural history (i.e., prevalence, incident detection, clearance/persistence) of cervical HPV and cervical neoplasia (i.e., squamous intraepithelial lesions; SIL) in a large prospective cohort of 2,584 HIV-seropositive and 915 HIV-seronegative women. Marijuana use was classified as ever/never, current/not current, and by frequency and duration of use. No positive associations were observed between use of marijuana, and either cervical HPV infection or SIL. The findings were similar among HIV-seropositive and HIV-seronegative women, and in tobacco smokers and nonsmokers. These data suggest that marijuana use does not increase the burden of cervical HPV infection or SIL.

Entities:  

Mesh:

Year:  2010        PMID: 20160270      PMCID: PMC2874245          DOI: 10.1158/1055-9965.EPI-09-1053

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

Review 1.  The cannabinoid system and immune modulation.

Authors:  Thomas W Klein; Cathy Newton; Kellie Larsen; Lily Lu; Izabella Perkins; Liang Nong; Herman Friedman
Journal:  J Leukoc Biol       Date:  2003-07-01       Impact factor: 4.962

2.  Marijuana use and cancer incidence (California, United States).

Authors:  S Sidney; C P Quesenberry; G D Friedman; I S Tekawa
Journal:  Cancer Causes Control       Date:  1997-09       Impact factor: 2.506

3.  Marijuana use and increased risk of squamous cell carcinoma of the head and neck.

Authors:  Z F Zhang; H Morgenstern; M R Spitz; D P Tashkin; G P Yu; J R Marshall; T C Hsu; S P Schantz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

4.  Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors.

Authors:  A B Moscicki; J Palefsky; J Gonzales; G K Schoolnik
Journal:  Pediatr Res       Date:  1990-11       Impact factor: 3.756

5.  Marijuana smoking--possible cause of head and neck carcinoma in young patients.

Authors:  P J Donald
Journal:  Otolaryngol Head Neck Surg       Date:  1986-04       Impact factor: 3.497

6.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

7.  Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.

Authors:  Darcy F Phelan; Stephen J Gange; Linda Ahdieh-Grant; Shruti H Mehta; Gregory D Kirk; Keerti Shah; Patti Gravitt
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

8.  Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco.

Authors:  S H Barsky; M D Roth; E C Kleerup; M Simmons; D P Tashkin
Journal:  J Natl Cancer Inst       Date:  1998-08-19       Impact factor: 13.506

9.  Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.

Authors:  Howard D Strickler; Joel M Palefsky; Keerti V Shah; Kathryn Anastos; Robert S Klein; Howard Minkoff; Ann Duerr; L Stewart Massad; David D Celentano; Charles Hall; Melissa Fazzari; Susan Cu-Uvin; Melanie Bacon; Paula Schuman; Alexandra M Levine; Amanda J Durante; Stephen Gange; Sandra Melnick; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

10.  Cervical human papillomavirus infection in the female population in Barcelona, Spain.

Authors:  Silvia de Sanjose; Rosa Almirall; Belen Lloveras; Rebeca Font; Mireia Diaz; Nubia Muñoz; Isabel Català; Chris J L M Meijer; Peter J F Snijders; Rolando Herrero; F Xavier Bosch
Journal:  Sex Transm Dis       Date:  2003-10       Impact factor: 2.830

View more
  6 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

Review 2.  Biology of human papillomavirus-related oropharyngeal cancer.

Authors:  Jason D Howard; Christine H Chung
Journal:  Semin Radiat Oncol       Date:  2012-07       Impact factor: 5.934

3.  Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study.

Authors:  Marisa C Eisenberg; Rafael Meza; Andrew F Brouwer; Lora P Campredon; Heather M Walline; Brittany M Marinelli; Christine M Goudsmit; Trey B Thomas; Rachel L Delinger; Yan Kwan Lau; Emily C Andrus; Thankam Nair; Thomas E Carey
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

Review 4.  Enhancement of Conventional and Photodynamic Therapy for Treatment of Cervical Cancer with Cannabidiol.

Authors:  Radmila Razlog; Cherie Ann Kruger; Heidi Abrahamse
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

5.  Concurrent and Concordant Oral and Genital High-Risk Human Papillomavirus in the United States: Results from the National Health and Nutrition Examination Survey.

Authors:  James Custer; Riddhi Patel; George L Delclos; Stacia M DeSantis
Journal:  J Infect Dis       Date:  2021-04-23       Impact factor: 5.226

Review 6.  Critical appraisal of the potential use of cannabinoids in cancer management.

Authors:  Belinda J Cridge; Rhonda J Rosengren
Journal:  Cancer Manag Res       Date:  2013-08-30       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.